載入...
The value of innovation under value-based pricing
OBJECTIVE: The role of cost-effectiveness analysis (CEA) in incentivizing innovation is controversial. Critics of CEA argue that its use for pricing purposes disregards the ‘value of innovation’ reflected in new drug development, whereas supporters of CEA highlight that the value of innovation is al...
Na minha lista:
| 發表在: | J Mark Access Health Policy |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Co-Action Publishing
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4826462/ https://ncbi.nlm.nih.gov/pubmed/27123192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/jmahp.v4.30754 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|